European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting the drug.
InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.
I had both breasts removed so I could be here for my daughter
Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...